OncoCyte Corp (OCX) PT Lowered to $4 at Needham & Company
Tweet Send to a Friend
Needham & Company analyst Mike Matson lowered the price target on OncoCyte Corp (NASDAQ: OCX) to $4.00 (from $5.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
